Form 4: Centessa Pharmaceuticals Executive Gregory M. Weinhoff Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals, reports the disposal of shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals plc, filed a Form 4 on July 2, 2024, reporting changes in beneficial ownership.
- On June 30, 2024, Weinhoff disposed of 11,742 ordinary shares at a price of $9.03 per share.
- This disposal was to cover tax withholding obligations related to the vesting of restricted share units.
- Following the transaction, Weinhoff beneficially owns 253,369 ordinary shares directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to share disposal for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the disposal of shares by a company officer.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of share disposal transaction. |
| 07/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.